Pages that link to "Q50925115"

The following pages link to Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL. (Q50925115):

Displaying 16 items.

• Characterization of Δ7/11, a functional prolactin-binding protein (Q24300561) (← links)
• The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation (Q34075597) (← links)
• Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis (Q34152172) (← links)
• 16-kDa Prolactin Reduces Angiogenesis, but Not Growth of Human Breast Cancer Tumors In Vivo (Q34346132) (← links)
• Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression. (Q36074071) (← links)
• MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy (Q36802746) (← links)
• Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland. (Q37060346) (← links)
• NF-kappa B: a new player in angiostatic therapy (Q37088045) (← links)
• Vasoinhibins: novel inhibitors of ocular angiogenesis (Q37188138) (← links)
• 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy (Q38021361) (← links)
• Pathophysiology and epidemiology of peripartum cardiomyopathy (Q38200908) (← links)
• New insights in prolactin: pathological implications (Q38381546) (← links)
• Investigating the effect of longitudinal micro-CT imaging on tumour growth in mice (Q39619704) (← links)
• Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases. (Q47271598) (← links)
• PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin. (Q48301035) (← links)
• Regulator of Angiogenesis and Vascular Function: A 2019 Update of the Vasoinhibin Nomenclature (Q64058593) (← links)